Medical cannabis could save NHS £4 billion each year
Allowing medical cannabis to be prescribed on the NHS for chronic pain could save the state healthcare provider almost £4 billion annually,
top of page
Blog
At Drug Science we like to cover different topics relating to drugs. These topics cover the many different ways that psychoactive substances have an impact on our culture and society.
Hallie Heeg, Ana Morari, Michael Lynskey and John JD Turner
Sep 242 min read
An exploration of medical professionals’ attitudes, perceived knowledge and concerns around medical cannabis in the United Kingdom
In the UK, there are over 40,000 specialist clinicians who are eligible to prescribe cannabis-based medical products (CBMPs); however, only
Alkyoni Anthanasiou-Fragkouli
Sep 22 min read
Key Achievements of T21
Since its inception in 2019, T21 has strived to create the largest body of evidence for the safety and efficacy of medical cannabis, providi
James Bunn
Jul 312 min read
Suicidal Ideation in Medicinal Cannabis Patients: A 12-Month Prospective Study
To document the prevalence and correlates of suicidal ideation (SI) among individuals seeking cannabis-based medicinal products (CBMPs); to
Michael Lynskey
Jun 172 min read
Prescribed Medical Cannabis Use Among Older Individuals: Patient Characteristics and Improvements in Well‑Being: Findings from T21
There are important differences between individuals aged 65+ years and younger individuals receiving cannabis-based medicinal products. Olde
Alkyoni Anthanasiou-Fragkouli
Jun 62 min read
Prescribed Medicinal Cannabis for the Treatment of Chronic Pain Comorbid with Depression: Real World Evidence from Project Twenty21
Chronic pain is one of the most common conditions for which people seek treatment with cannabis-based medicinal products (CBMPs) and there i
Dr Anne Schlag, Professor David Nutt and more
Mar 121 min read
Medicinal cannabis for treating PTSD and comorbid depression: Real World Evidence from Project T21
Authors Michael Lynskey, Alkyoni Athanasiou-Fragkouli, Hannah Thurgur, Anne Schlag and David Nutt Published March 12, 2024 Background...
Drug Science
Jan 72 min read
Results from Long COVID trial published
We are delighted to share the news that the results from the Long COVID trial have been published by the British Journal of Clinical Pharmac
Drug Science
Nov 2, 20231 min read
Know Your Rights: Medical Cannabis
Download the free patient Legal Guidance by Drug Science around Medical Cannabis
Dr Hannah Thurgur, Dr Anne Schlag, and more
Aug 31, 20231 min read
Cannabis-based medicinal products for the treatment of Long COVID symptoms: current and potential applications
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection can result in a range of persistent symptoms impacting everyday funct
Mags Houston
Jul 24, 20233 min read
The Drug Science Podcast and Medical Cannabis
the Drug Science podcast has been a vital and inspiring source of information for me when it comes to UK drug policy.
Jon Waldron, Meryem Grabski, and more
Jul 10, 20232 min read
Impact of the introduction of medical cannabis in the UK on risk perception and recreational use of cannabis: A longitudinal and cross-sectional analysis
Cannabis was rescheduled in the UK in November 2018 so that it can now be prescribed as a treatment for certain medical conditions.
Kylie O’Brien, Justin Beilby and more
May 25, 20232 min read
Medicinal cannabis for pain: Real-world data on three-month changes in symptoms and quality of life
Internationally, one of the most common conditions for which people seek medicinal cannabis (MC) is chronic pain. However, relatively little
Michael White and Nicholas Burns
May 25, 20231 min read
Does the co-use of cannabis exacerbate the effect of alcohol on the risk of crashing? A systematic review and meta-analysis
Does the co-use of cannabis exacerbate the effect of alcohol on the risk of crashing? A systematic review and meta-analysis
Professor Michael Lynskey, Dr Anne Schlag and more
May 5, 20232 min read
Characteristics of and 3-month health outcomes for people seeking treatment with prescribed cannabis
Medicinal cannabis has been legal in the UK since 2018 but there is limited information about characteristics of people seeking prescribed
Louise McConnell
Mar 20, 20232 min read
Combating the stigma: a T21 success story
By Louise McConnell Although medical cannabis has been legal in the UK for more than four years, there still exists a great deal of...
Peter Sunderland, Professor David Nutt and more
Mar 14, 20232 min read
Medication sparing after medical cannabis initiation: A case study of a chronic pain patient in T21
Authors Peter Sunderland, David J Nutt, and Anne Katrin Schlag Published March 14th, 2023 Prescribed cannabinoids are legal in the UK and...
Drug Science
Feb 13, 20233 min read
Parents and scientists back new study into benefits of cannabis-based medications for children with severe epilepsy
Today, on International Epilepsy Day, patient group MedCan Support, scientific body Drug Science and tech-platform Alta Flora announce...
Drug Science
Jan 16, 20234 min read
Drug Science’s medical cannabis patient registry (T21) to continue for a fourth year
Today (16 January 2023) Drug Science announces that its medicinal cannabis patient registry ‘T21’ is continuing for a fourth year — and...
Professor Michael Lynskey, Dr Anne Schlag and more
Nov 3, 20224 min read
The value of real world evidence: The case of medical cannabis
Authors Anne Katrin Schlag, Rayyan Zafar, Michael Lynskey, Lawrence D Phillips, Alkyoni Athanasiou-Fragkouli, David J Nutt Published...
Michael White and Nicholas Burns
Aug 15, 20222 min read
How to read a paper on the short-term impairing effects of cannabis: A selective and critical review of the literature
Author Michael A White, Nicholas R Burns Published August 15, 2022 Abstract The prosecution of cannabis-presence driving offences (in the...
bottom of page